Abundant Fas expression by gastrointestinal stromal tumours may serve as a therapeutic target for MegaFasL
Bart Rikhof(University of Groningen), Albert J.H. Suurmeijer(University Medical Center Groningen)
Cited by 18
Related Papers
‘Big’-Insulin-Like Growth Factor–II Signaling Is an Autocrine Survival Pathway in Gastrointestinal Stromal Tumors
|American Journal Of Pathology|2012|18
Novel <i>EWSR1::GFI1B</i> gene fusion in angiofibroma of soft tissue
|Histopathology|2023|5